These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28041909)

  • 1. Macrophage activation syndrome: Experience in the questioned role of etoposide.
    Conde LF; Aedo KP; Miraval-Niño de Guzmán T
    Reumatol Clin; 2017; 13(4):239-240. PubMed ID: 28041909
    [No Abstract]   [Full Text] [Related]  

  • 2. A continuous infusion of etoposide and doxorubicin for refractory MAS management.
    Jin J
    Neth J Med; 2016 Aug; 74(7):324-5. PubMed ID: 27571955
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome of PatientsWith Systemic Onset Juvenile Idiopathic Arthritis With Macrophage Activation Syndrome at Onset.
    Raghuram J; Gornale VK; Rao AP
    Indian Pediatr; 2021 Jan; 58(1):87. PubMed ID: 33452788
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
    Minoia F; Davì S; Horne A; Demirkaya E; Bovis F; Li C; Lehmberg K; Weitzman S; Insalaco A; Wouters C; Shenoi S; Espada G; Ozen S; Anton J; Khubchandani R; Russo R; Pal P; Kasapcopur O; Miettunen P; Maritsi D; Merino R; Shakoory B; Alessio M; Chasnyk V; Sanner H; Gao YJ; Huasong Z; Kitoh T; Avcin T; Fischbach M; Frosch M; Grom A; Huber A; Jelusic M; Sawhney S; Uziel Y; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
    Arthritis Rheumatol; 2014 Nov; 66(11):3160-9. PubMed ID: 25077692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of macrophage activation syndrome due to systemic onset juvenile idiopathic arthritis with antithymocyte globulin.
    Ozturk K; Ekinci Z
    Rheumatol Int; 2015 Oct; 35(10):1779-80. PubMed ID: 26210998
    [No Abstract]   [Full Text] [Related]  

  • 6. No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis.
    Kiuchi Z; Ogura M; Sato M; Kamei K; Ishikura K; Abe J; Ito S
    Scand J Rheumatol; 2019 May; 48(3):246-248. PubMed ID: 30406708
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
    Wagner-Weiner L
    Pediatr Ann; 2015 Jun; 44(6):e142-7. PubMed ID: 26114369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 50 Years Ago in TheJournalofPediatrics: Hepatic Dysfunction in Systemic Juvenile Idiopathic Arthritis with Alleviation of Arthritis: The First Description of Macrophage Activation Syndrome?
    Ashkenazi L; Hashkes PJ
    J Pediatr; 2021 Jul; 234():64. PubMed ID: 34172168
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrophage Activation Syndrome secondary to Systemic Juvenile Idiopathic Arthritis: A Case Report.
    Kafle R; Bhatta A; Gami S; Sapkota A; Sharma D; Yadav A; Chikanbanjar VK
    JNMA J Nepal Med Assoc; 2021 Nov; 59(243):1166-1169. PubMed ID: 35199753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 17-year-old girl with severe respiratory failure and circulatory shock.
    Gutierrez D; Guy L; Katikireddi VS; Butler JP; Gowardman J
    Med J Aust; 2011 Oct; 195(7):414-5. PubMed ID: 21978351
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophage Activation Syndrome in a Child with Juvenile Idiopathic Arthritis Secondary to SARS-CoV-2.
    Akturk H; Tanyildiz M; Erbey F; Tasdemir M; Celikyurt A; Gonen E; Bilge I
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34028559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canakinumab for Pulmonary Artery Hypertension and Macrophage Activation Syndrome Associated with Uncontrolled Systemic Juvenile Idiopathic Arthritis.
    Paim LB; Landim MLL; Firmino SL; Monteiro CMBE; Cordeiro LR; de Araujo FG; de Carvalho JF
    Indian J Pediatr; 2021 Jun; 88(6):608-609. PubMed ID: 33742412
    [No Abstract]   [Full Text] [Related]  

  • 13. Tapering Doses of Methylprednisolone Pulse in the Treatment of Macrophage Activation Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.
    Loganathan S; Banday A; Jindal AK; Sudhakar M; Patra N; Pulipaka S; Bansal R; Mohanandia B; Singh S
    Indian J Pediatr; 2021 Oct; 88(10):1056. PubMed ID: 34196929
    [No Abstract]   [Full Text] [Related]  

  • 14. [Macrophage activation syndrome in a patient with systemic juvenile idiopathic arthritis].
    Tavares AC; Ferreira GA; Guimarães LJ; Guimarães RR; Santos FP
    Rev Bras Reumatol; 2015; 55(1):79-82. PubMed ID: 25575650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome.
    Yasin S; Solomon K; Canna SW; Girard-Guyonvarc'h C; Gabay C; Schiffrin E; Sleight A; Grom AA; Schulert GS
    Rheumatology (Oxford); 2020 Feb; 59(2):442-445. PubMed ID: 31359055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Macrophage activation syndrome: diagnosis and emergency management].
    Pillet P; Lagarde M; Bailhache M; Berciaud S; Richer O
    Arch Pediatr; 2015 May; 22(5 Suppl 1):143-4. PubMed ID: 26112562
    [No Abstract]   [Full Text] [Related]  

  • 17. [Macrophage activation syndrome in Chinese children with systemic onset juvenile idiopathic arthritis].
    Li CF; He XH; Kuang WY; Han TX; Zhou YF
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):806-11. PubMed ID: 17274865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient natural killer cell dysfunction associated with interleukin-18 overproduction in systemic juvenile idiopathic arthritis.
    Takakura M; Shimizu M; Yakoyama T; Mizuta M; Yachie A
    Pediatr Int; 2018 Oct; 60(10):984-985. PubMed ID: 30345698
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
    Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
    Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.